Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(12 sites)
United States
UC Davis, Sacramento, California Emory Winship Cancer Institute, Atlanta, Georgia LSU Health Sciences Center - Shreveport, Shreveport, Louisiana Montefiore Medical Center, The Bronx, New York University of North Carolina, Chapel Hill, North Carolina